PAS
TNDM icon

Park Avenue Securities’s Tandem Diabetes Care TNDM Stock Holding History

Park Avenue Securities’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,647
Closed -$204K – 1827
2026
Q1 		$204K Buy
10,647
+1,244
+13% +$27K ﹤0.01% 1469
2025
Q4 		$207K Buy
+9,403
New +$170K ﹤0.01% 1445
2025
Q3 		– Sell
-10,938
Closed -$204K – 1684
2025
Q2 		$204K Sell
10,938
-770
-7% -$15.3K ﹤0.01% 1429
2025
Q1 		$224K Buy
11,708
+2,794
+31% +$81.8K ﹤0.01% 1095
2024
Q4 		$321K Buy
8,914
+2,286
+34% +$77.3K ﹤0.01% 1262
2024
Q3 		$281K Sell
6,628
-1,951
-23% -$82.7K ﹤0.01% 1205
2024
Q2 		$346K Sell
8,579
-71
-0.8% -$2.96K ﹤0.01% 1131
2024
Q1 		$306K Buy
8,650
+1,459
+20% +$39.1K ﹤0.01% 1167
2023
Q4 		$213K Buy
+7,191
New +$149K ﹤0.01% 1274

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Park Avenue Securities's TNDM Position: Q2 2026 in Review

Park Avenue Securities sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 10,647 shares — an estimated $204K sold.

Park Avenue Securities first reported a position in TNDM in Q4 2023 and held it in 9 quarters. The position peaked at $346K in Q2 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Park Avenue Securities reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Park Avenue Securities sold 10,647 Tandem Diabetes Care shares in Q2 2026, an estimated $204K.
  • Park Avenue Securities first reported a position in Tandem Diabetes Care in Q4 2023 and held it in 9 quarters.
  • Park Avenue Securities's Tandem Diabetes Care position peaked at $346K in Q2 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.